ahlam1399
09-21-2016, 05:25 PM
AstraZeneca pulls cancer drug application in Europe
LONDON (Reuters) - AstraZeneca has pulled an application seeking European approval to sell its experimental cancer drug cediranib in combination with chemotherapy to treat ovarian cancer because of late-stage questions raised by regulators reviewing the product.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=tyW3t9JTcPQ:p3vTHk5fXlE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=tyW3t9JTcPQ:p3vTHk5fXlE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=tyW3t9JTcPQ:p3vTHk5fXlE:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=tyW3t9JTcPQ:p3vTHk5fXlE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=tyW3t9JTcPQ:p3vTHk5fXlE:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/tyW3t9JTcPQ
LONDON (Reuters) - AstraZeneca has pulled an application seeking European approval to sell its experimental cancer drug cediranib in combination with chemotherapy to treat ovarian cancer because of late-stage questions raised by regulators reviewing the product.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=tyW3t9JTcPQ:p3vTHk5fXlE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=tyW3t9JTcPQ:p3vTHk5fXlE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=tyW3t9JTcPQ:p3vTHk5fXlE:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=tyW3t9JTcPQ:p3vTHk5fXlE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=tyW3t9JTcPQ:p3vTHk5fXlE:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/tyW3t9JTcPQ